Marie C. Bradley, PhD

Dr
US Food and Drug Administration

Poster(s):

• (104) Impact of Angiotensin-Receptor-Blocker (ARB) Recalls Due to Nitrosamine Contamination on ARB Utilization in Germany: A Multinational Study with a Common Protocol Led by FDA
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (86) Impact of Angiotensin-Receptor-Blocker (ARB) Recalls Due to Nitrosamine Contamination on ARB Utilization in The U.S., Canada, and Denmark
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (149) Inverse Probability Treatment Weighting Versus Propensity Score Matching in The Sentinel System: A Test Case
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST